Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
about
Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesisEarly events during neoplastic progression in Barrett's esophagusLGI proteins in the nervous system.Signaling pathways in the molecular pathogenesis of adenocarcinomas of the esophagus and gastroesophageal junctionQuantitative Shotgun Proteomics Unveils Candidate Novel Esophageal Adenocarcinoma (EAC)-specific Proteins.Biomarkers in Barrett's Esophagus.Medical and endoscopic management of high-grade dysplasia in Barrett's esophagusEmerging roles of Kruppel-like factor 6 and Kruppel-like factor 6 splice variant 1 in ovarian cancer progression and treatment.New strategies in Barrett's esophagus: integrating clonal evolutionary theory with clinical managementResidues 240-250 in the C-terminus of the Pirh2 protein complement the function of the RING domain in self-ubiquitination of the Pirh2 protein.ErbB receptors in the biology and pathology of the aerodigestive tractERBBs in the gastrointestinal tract: recent progress and new perspectives.Barrett's esophagus: can biomarkers predict progression to malignancy?A novel oncoprotein Pirh2: rising from the shadow of MDM2.Barrett's esophagus: genetic and cell changes.Expression of LGI1 Impairs Proliferation and Survival of HeLa Cells.
P2860
Q24602426-31A88B47-5C17-4197-BF19-F9433D1E9644Q26825349-49E357C2-A3BA-495D-AEEB-3C83822B0A00Q26998200-061EFA49-7C4E-4E86-A855-FAC6505D2AFEQ27026253-C3E4D6AC-E7D8-48C8-B5D8-6008C1096249Q33771039-1A71338C-117B-4922-86F0-E8E3E37A60C7Q34011000-FF69248E-5A70-4814-8EFA-FC6D4A2984ABQ34050233-9336D4CE-8E99-4C0B-8649-6AE4A829F22DQ34698278-891F7A0D-633F-498D-A526-A9DE539293F4Q35057339-B06A6A17-945C-48D9-8EB3-A22D4B07C930Q35075426-B3656BEA-9763-4404-B02B-AB19A4408917Q37263452-D503A1A7-B587-4D68-A7DC-42EFB29399FAQ37337542-2969CC43-C9EE-462E-9F4A-3946DE38F185Q37345836-DD361CCB-506F-4F03-9F77-322F81ED0F14Q37834073-AB03062A-30AD-4457-ADC3-F6957B6298D5Q37939277-B0B07FD3-8910-4192-AA9A-5E69EF08393CQ42138210-61E0972A-8D4B-439C-9A6F-016E20A85AED
P2860
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@ast
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@en
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@nl
type
label
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@ast
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@en
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@nl
prefLabel
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@ast
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@en
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@nl
P2093
P2860
P356
P1476
Alterations in Barrett's-related adenocarcinomas: a proteomic approach.
@en
P2093
DunFa Peng
Essam A Sheta
Ira L Goldknopf
Kay Washington
Steven M Powell
Wael El-Rifai
P2860
P304
P356
10.1002/IJC.23258
P577
2008-03-01T00:00:00Z